search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
NEWS


CASELLA LAUNCHES PROGRAMME OF FREE EXPERT WEBINARS ON ENVIRONMENTAL HAZARD MONITORING


Casella has announced its schedule of industry-leading webinars for 2024 focusing on environmental hazard monitoring, covering noise, air sampling, and vibration.


The schedule of free-to-attend, accessible webinars cover Casella’s core areas of expertise, including workplace monitoring for noise, environmental boundary, hand and arm vibration, and asbestos sampling, as well as instrumentation usage and best practice.


Reaching worldwide attendees, two sessions will be run on each date, one at 10am and a later session at 3pm to ensure learners across multiple time zones can benefit. Each webinar will conclude with a Q&A session to recap what was discussed.


Webinars focusing on the topic of noise will cover workplace noise regulations, employer responsibilities regarding noise control and detail about understanding parameters and exposure calculations. Other webinars cover the use of instruments such as sound level meters and noise dosimeters, with practical advice and best practice.


IOM OFFERS OCCUPATIONAL EXPOSURE LIMIT DOCUMENTATION FOR PHARMACEUTICAL COMPANIES


IOM set to offer Occupational Exposure Limit documentation for pharmaceutical companies to enhance workplace safety.


Enhancing an already comprehensive offering of workplace protection IOM is pleased to announce the addition of reviewing and creating of Active Pharmaceutical Ingredient Occupational Exposure Limits (API OELs) to its services.


Helping those working in pharmaceutical manufacturer, and biotechnology to ensure compliance to Control of Substances Hazardous to Health Regulations (COSHH) regulation, worker health and drive efficiency when working with Active Pharmaceutical Ingredients. These comprehensive documents will review literature and draw upon the decades of academic and industry experience to put in place the appropriate Occupational Exposure Limits.


IOM’s API OELs include:


Threshold limit values: Specifying maximum allowable concentrations over an eight-hour workday. The OEL is based on 1% of the therapeutic dose, taking into account inhalation.


6


For air sampling, Casella is offering webinars that teach participants to correctly calibrate and use air sampling pumps as well as the standards, requirements and methodologies pertaining to the practice of air sampling. More specific webinars will touch on the monitoring of specific airborne hazards such as asbestos and other harmful dusts.


Casella is also offering webinars on the data required for environmental monitoring including the key parameters expected for noise, particulate and vibration within regulations, another will explain the proper installation and usage of these boundary monitoring units. For hand arm vibration syndrome (HAVS), a webinar reviewing terminology about HAV measurement, legislation and exposure limits, as well as how to measure exposure on the tool correctly and subsequently calculate exposure levels.


https://www.casellasolutions.com/uk/en/support/training/casella-webinars.html www.casellasolutions.com


The series will run from 11 April to 24 November, to find specific dates or to sign up for any of these webinars, free of charge, click here.


Substance description: Summarising the substance, chemical properties, and precautionary statements.


Animal and human studies:Detailing toxicity, carcinogenicity, reproductive toxicity, and clinical pharmacology.


Email: info@iom-world.org www.iom-world.org/lab-services/pharmaceuticals


www.tomorrowshs.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56